SurModics (SRDX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Core Insights - SurModics reported revenue of $29.57 million for the quarter ended June 2025, a decrease of 2.6% year-over-year, but exceeded the Zacks Consensus Estimate by 4.29% [1] - The company achieved an EPS of $0.06, a significant improvement from -$0.27 in the same quarter last year, resulting in an EPS surprise of 128.57% compared to the consensus estimate of -$0.21 [1] Revenue Breakdown - Product sales amounted to $16.76 million, surpassing the average estimate of $15.69 million, but reflecting a year-over-year decline of 4.6% [4] - Revenue from research, development, and other sources was $3.15 million, exceeding the average estimate of $2.37 million, marking a year-over-year increase of 35.7% [4] - Royalties and license fees generated $9.66 million, slightly below the estimated $10.2 million, representing a year-over-year decrease of 7.7% [4] Stock Performance - SurModics shares have returned +12.9% over the past month, outperforming the Zacks S&P 500 composite's +1.9% change [3] - The stock currently holds a Zacks Rank 5 (Strong Sell), indicating potential underperformance relative to the broader market in the near term [3]